Modeling the Cost and Health Impacts of Diagnostic Strategies in Patients with Suspected Transthyretin Cardiac Amyloidosis
Background Transthyretin cardiac amyloidosis (ATTR‐CMP) is an increasingly recognized and treatable cause of heart failure with preserved ejection fraction. Multimodality cardiac imaging is recommended for ATTR‐CMP diagnosis, but its cost‐effectiveness in current clinical practice has not been well...
Main Authors: | Yin Ge, Ankur Pandya, Sarah A. M. Cuddy, Amitoj Singh, Avinainder Singh, Sharmila Dorbala |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-09-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.122.026308 |
Similar Items
-
Cardiac scintigraphy-centered diagnostic process in transthyretin cardiac amyloidosis
by: Ilknur Ak Sivrikoz, et al.
Published: (2020-07-01) -
Revisiting transthyretin related cardiac amyloidosis: Case report and review of literature
by: Munish Sharma, et al.
Published: (2018-05-01) -
Frailty in Older Patients with Transthyretin Cardiac Amyloidosis
by: Stéphanie Cazalbou, et al.
Published: (2023-12-01) -
Coexistence of Light Chain and Transthyretin Cardiac Amyloidosis
by: Abhishek Gami, MD, et al.
Published: (2024-04-01) -
Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure
by: Gabriela Molina O, et al.
Published: (2014-11-01)